Phase II study of gemcitabine combined with uracil-tegafur in metastatic pancreatic cancer.
Lee J, Park JO, Kim WS, Lee SI, Song SY, Lim DH, Choi SH, Heo JS, Lee KT, Lee JK, Kim K, Jung CW, Im YH, Lee MH, Kang WK, Park K.
Lee J, et al. Among authors: lee si, lee kt, lee mh, lee jk.
Oncology. 2004;66(1):32-7. doi: 10.1159/000076332.
Oncology. 2004.
PMID: 15031596
Clinical Trial.